ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Ionis Begins ALS Clinical Trial americanpharmaceuticalreview
October 28, 2020Ionis Pharmaceuticals announced the first patients have been dosed with ION541 (also known as BIIB105), an investigational antisense medicine being developed as a potential therapy to treat most forms of amyotrophic lateral sclerosis (ALS) regardless ...
Pharma Sources Insight July 2025
